Page 9 - Astrazeneca

Astrazeneca-Sputnik jabs in combo show a better immune response: RDIF

Preliminary results from Azerbaijan trials have been announced

AstraZeneca's antibody drug prevents Covid-19 in high-risk groups

Results from Astra's study found no one in the trial who received the cocktail contracted severe Covid-19 or died in relation to the disease, the company said in a statement Friday

Pfizer and Astra vaccines less effective after 90 days, says study

The Oxford University study found that 90 days after a second shot of the Pfizer or Astra vaccine, their efficacy in preventing infections had slipped to 75 per cent and 61 per cent, respectively

Pfizer, AstraZeneca vaccines less effective against Delta variant: Study

The COVID vaccines by Pfizer and AstraZeneca are less effective against the Delta variant compared to the Alpha variant, according to a study led by researchers at the University of Oxford

AstraZeneca Pharma India Q1 net profit declines 45% to Rs 10.24 cr

Drug firm AstraZeneca Pharma India on Monday reported a 45.03 per cent decline in its net profit to Rs 10.24 crore for the June ended quarter

Nepal receives first batch of AstraZeneca vaccine against Covid from Japan

Nepal received the first batch of AstraZeneca COVID-19 vaccine from Japan on Saturday, local media reports said.

Combining AstraZeneca and mRNA Covid vaccines is effective: Danish study

A growing number of countries are looking at switching to different Covid vaccines for second doses, a measure necessary in Denmark after health authorities discontinued AstraZeneca's vaccine in April

AstraZeneca's nasal vax prevents Covid spread in animal models

The trial, led by researchers including from the US National Institutes of Health (NIH) and the University of Oxford, UK, was published in the journal Science Translational Medicine.

Over 18 and considering the AstraZeneca vaccine? This may help you decide

Let's look at the evidence

Astra's Covid-19 vaccine sales triple in Q2, top $1 billion in H1

Firm exploring whether vaccine biz is sustainable for next 5-10 years: Official

Covishield single jab efficacy drops after 16 weeks in 60+ age grp: Report

The efficacy of the single dose of Oxford-Astrazeneca Covid-19 vaccine Covishield dropped at 16 weeks for those above the age of 60

AstraZeneca to apply for Covid-19 vaccine approval in US later in 2021

AstraZeneca reported first-half revenue of $15.5 billion, up 23 per cent

AstraZeneca finds small clot risk after first dose of Vaxzevria vaccine

No extra risk after second dose shows study led and funded by drug maker

Pfizer, Astra vaccine antibody levels may decline after 2-3 months: Lancet

Total antibody levels start to wane six weeks after complete immunisation with Pfizer and AstraZeneca vaccines, and can reduce by more than 50 per cent over 10 weeks, according to The Lancet journal

Russia OKs testing combination of Sputnik, AstraZeneca vaccine shots

Russia's health officials have given a go-ahead to testing a combination of the AstraZeneca coronavirus shot and the single-dose version of the domestically developed Sputnik V vaccine

What makes Covid-19 delta variant such a threat? Ten questions answered

The delta variant has some characteristics that give it a better chance of causing an infection, which means it escapes initial shield provided by antibodies, but vaccinated people are at a lower risk

Prices of oral diabetes drugs set to fall as patents near expiry date

The diabetes segment has been growing faster than the country's overall drug market

World Coronavirus Dispatch: Australia had no Plan B, it came back to haunt

WHO warns of 'chaos' if individuals mix shots, Astra-Oxford said to be looking at tweaking vaccine to prevent rare clots, and other pandemic-related news across the globe

Sputnik, Astrazeneca mix & match booster dose results expected by July end

RDIF, Russia's sovereign wealth fund, and SII have also announced cooperation to produce the Russian Sputnik vaccine against coronavirus in India.

Canada to donate 17.7 mn AstraZeneca Covid-19 vaccine to other countries

Canada announced its decision to donate 17.7 million doses of the AstraZeneca coronavirus vaccine to low- and middle-income countries